Clinical Research Trials

Cardiac Risk Reduction and Rehabilitation Program


Cardiology

Cardiothoracic Surgery

  • GIK in Diabetic CABG Pts

Cardiovascular Catheterization and Intervention Program

  • ACC data registry of cardiovascular outcomes
  • ASCED-HF - A double-blind, placebo-controlled multicenter acute study of clinical effectiveness of nesiritide in subjects with decompensated HF
  • BALANCE - Treatment of hyponatremia based on lizivaptan in NYHA class III/IV cardiac patient evaluaton
  • CAPTURE II
  • EMPHASIS-HF - The Effect of eplerenone vs placebo on cardiovascular mortality and heart failure hospitalization in subjects with NYHA Class II chronic systolic heart failure
  • Event registry
  • FREEDOM
  • GRAVITAS - Gauging responseness with a verigyNow assay, impact on Thrombosis and Safety
  • IMPELLA
  • MASS COMM
  • MASS DAC
  • National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry
  • PAD
  • PROTECT
  • TOPCAT - Treatment of Preserved Cardiac Function heart failure with an aldosterone antagonist (NHLBI funded)
  • VIRGO
  • XIENCE V - Everolimus eluting coronary stent system USA post-approval study
  • TRA - Ocular safety study A randomized, double bline placebo controlled study to evaluate the ocular safety of SCH 530348 in subjects with atherosclerotic disease.
  • Effect of Nutrition and Weight modification on endothelial function
  • Alterations in fat cell derived adipocytokine expression before and after weight loss
  • Inflammation and Vascular Dysfunction in Obesity
  • The clinical utility of endothelial function in peripheral arterial disease...assessment short and long term cardiovascular risk in patients with peripheral arterial disease (PAD)

Heart Valve Repair and Replacement Surgery


CLINICAL RESEARCH TRIALS


Warning

Your Session will expire in 5 minutes

Please click the "Continue Session" button below to continue using the website. To end your session please click the "End Session" button below. After 5 minutes of inactivity your session will be terminated and you will be required to log in again.